東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

A Differentially Methylated Region A...

Mullins, Lanie KateLynn.

FindBook

Google Book

Amazon

博客來

A Differentially Methylated Region Analysis Between Three Disease States of Major Depressive Disorder in Primarily African-American Cohorts.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	A Differentially Methylated Region Analysis Between Three Disease States of Major Depressive Disorder in Primarily African-American Cohorts./
作者:	Mullins, Lanie KateLynn.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2024,
面頁冊數:	156 p.
附註:	Source: Masters Abstracts International, Volume: 85-11.
Contained By:	Masters Abstracts International85-11.
標題:	Genetics. -
電子資源:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30997072
ISBN:	9798382584843

A Differentially Methylated Region Analysis Between Three Disease States of Major Depressive Disorder in Primarily African-American Cohorts.
Mullins, Lanie KateLynn.

A Differentially Methylated Region Analysis Between Three Disease States of Major Depressive Disorder in Primarily African-American Cohorts. - Ann Arbor : ProQuest Dissertations & Theses, 2024 - 156 p.

Source: Masters Abstracts International, Volume: 85-11.

Thesis (M.S.)--University of South Florida, 2024.

Major depressive disorder (MDD) is a common and debilitating disorder that affects millions of people worldwide. MDD is a multifactorial disease with no established mechanism currently able to explain all facets of the disease or its etiology. Feedback loop mechanisms have been posited to explain the interactions of psychological and physical components of the disease etiology. Epigenetics, specifically DNA-methylation analyses, can shed light on the interaction between the within-person environment resulting from MDD symptomology, the persistence of the disease, and factors influencing remission. Here, a differentially methylated region analysis was conducted using samples derived from whole blood to interrogate the distinctions in epigenetic modifications among individuals currently experiencing, never having experienced, and in a state of remission from MDD in a predominantly African-American discovery cohort. The study participants (n=31 currently have MDD, n=41 remitted MDD, and n=72 have never had MDD) are a subsample from a larger prospective, longitudinal study, the Detroit Neighborhood Health Study. The replication cohort used to validate results consisted of a subsample of participants from the Grady Trauma Project (current MDD (n = 31), remitted MDD (n=41), and never having had MDD (n=72), using both targeted and de novo analyses. Differentially methylated region analyses were completed investigating three disease state comparisons: never vs. current, never vs. remitted, and current vs. never. A total of 134 DMRs were found among these comparisons in the discovery cohort, 11 of which were found within the replication cohort. Five DMRs, BCOR, SLFN12, CPT1B, PM20D1, and PRDM8, were differentially methylated among all three disease state comparisons. Gene set enrichment analysis was performed for significant DMRs in the DNHS cohort, implicating pathways related to regulatory pathways, metabolism, bone health, energy synthesis, neuroinflammation signaling, and the immune response. Several DMRs within both the never vs. remitted and never vs. current analyses were found to have effect sizes of opposite directions, which may suggest changes characteristic of remission. One gene in particular, PRDM8, was present across all three discovery analyses and, notably, exhibited consistent effect size directionality between the discovery analysis group and its associated replication group (never vs. current). These findings help to better inform our understanding of the interplay between epigenetic regulation and the physiological systems involved in MDD and underscore the importance of epigenetic regulation in MDD progression and remission, prompting further inquiry.

ISBN: 9798382584843Subjects--Topical Terms:

530508
Genetics.
Subjects--Index Terms:

Depression

A Differentially Methylated Region Analysis Between Three Disease States of Major Depressive Disorder in Primarily African-American Cohorts.
LDR:03919nmm a2200385 4500 001 2401160
005 20241015112548.5
006 m o d
007 cr#unu||||||||
008 251215s2024 ||||||||||||||||| ||eng d
020 $a 9798382584843
035 $a (MiAaPQ)AAI30997072
035 $a AAI30997072
035 $a 2401160
040 $a MiAaPQ $c MiAaPQ
100 1 $a Mullins, Lanie KateLynn. $3 3771232
245 1 2 $a A Differentially Methylated Region Analysis Between Three Disease States of Major Depressive Disorder in Primarily African-American Cohorts.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2024
300 $a 156 p.
500 $a Source: Masters Abstracts International, Volume: 85-11.
500 $a Advisor: Uddin, Monica.
502 $a Thesis (M.S.)--University of South Florida, 2024.
520 $a Major depressive disorder (MDD) is a common and debilitating disorder that affects millions of people worldwide. MDD is a multifactorial disease with no established mechanism currently able to explain all facets of the disease or its etiology. Feedback loop mechanisms have been posited to explain the interactions of psychological and physical components of the disease etiology. Epigenetics, specifically DNA-methylation analyses, can shed light on the interaction between the within-person environment resulting from MDD symptomology, the persistence of the disease, and factors influencing remission. Here, a differentially methylated region analysis was conducted using samples derived from whole blood to interrogate the distinctions in epigenetic modifications among individuals currently experiencing, never having experienced, and in a state of remission from MDD in a predominantly African-American discovery cohort. The study participants (n=31 currently have MDD, n=41 remitted MDD, and n=72 have never had MDD) are a subsample from a larger prospective, longitudinal study, the Detroit Neighborhood Health Study. The replication cohort used to validate results consisted of a subsample of participants from the Grady Trauma Project (current MDD (n = 31), remitted MDD (n=41), and never having had MDD (n=72), using both targeted and de novo analyses. Differentially methylated region analyses were completed investigating three disease state comparisons: never vs. current, never vs. remitted, and current vs. never. A total of 134 DMRs were found among these comparisons in the discovery cohort, 11 of which were found within the replication cohort. Five DMRs, BCOR, SLFN12, CPT1B, PM20D1, and PRDM8, were differentially methylated among all three disease state comparisons. Gene set enrichment analysis was performed for significant DMRs in the DNHS cohort, implicating pathways related to regulatory pathways, metabolism, bone health, energy synthesis, neuroinflammation signaling, and the immune response. Several DMRs within both the never vs. remitted and never vs. current analyses were found to have effect sizes of opposite directions, which may suggest changes characteristic of remission. One gene in particular, PRDM8, was present across all three discovery analyses and, notably, exhibited consistent effect size directionality between the discovery analysis group and its associated replication group (never vs. current). These findings help to better inform our understanding of the interplay between epigenetic regulation and the physiological systems involved in MDD and underscore the importance of epigenetic regulation in MDD progression and remission, prompting further inquiry.
590 $a School code: 0206.
650 4 $a Genetics. $3 530508
650 4 $a African American studies. $3 2122686
653 $a Depression
653 $a Epigenetics
653 $a Major depressive disorder
653 $a Community-based cohorts
653 $a Differential methylation
690 $a 0369
690 $a 0296
710 2 $a University of South Florida. $b Public Health. $3 1685156
773 0 $t Masters Abstracts International $g 85-11.
790 $a 0206
791 $a M.S.
792 $a 2024
793 $a English
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30997072